Diclofenac Epolamine
Product Images NDC 50436-1335

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 50436-1335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure of diclofenac epolamine, showing the molecular configuration of diclofenac and the epolamine moiety including a pyrrolidinyl group with ethanol substitution.*

FDA Label Image

Figure 1 And 2 (Diclofenac 02)

Two charts show patients achieving various levels of pain relief in a 14-day study of diclofenac epolamine patch versus placebo. Figure 1 shows results at day 3, while Figure 2 shows results at the end of the study. Both display percent of patients improved against percent improvement from baseline, with higher improvement noted for the diclofenac patch group compared to placebo.*

FDA Label Image

Figure 3 And 4 (Diclofenac 03)

Two line graphs showing patients achieving various levels of pain relief in a 7-day study of diclofenac epolamine patch versus placebo. The left graph presents data at Day 3 with percent improvement from baseline on the x-axis and percent of patients improved on the y-axis. The right graph shows similar data at the end of the study. Both graphs use distinct markers for diclofenac patch and placebo.*

FDA Label Image

Logo (Diclofenac 03a)

FDA Label Image

Logo (Diclofenac 03b)

FDA Label Image

Label Image (Lbl504361335)

Label for diclofenac epolamine topical system, 1.3% strength, by Unit Dose Services. The label includes dosing instructions, active ingredient, storage conditions (20-25°C), and multiple identifiers including NDC 50436-1335-1, manufacturer IBSa Institut Biochimique in Lugano, Switzerland, and placeholder text for lot number, expiration date, and serial number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.